Molecular Formula | C13H10Cl3N5 |
Molar Mass | 342.611 |
Solubility | Soluble in DMSO (>25 mg/ml) |
Appearance | solid |
Color | White to off-white |
Storage Condition | -20°C |
Stability | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month. |
In vitro study | In 1321N1 cells stably expressing rat P2X 7 receptors, A 438079 blocks BzATP-(10 μM) evoked changes in intracellular calcium concentrations with an IC 50 of 321 nM. A 438079 is also selective for the P2X 7 receptor, at concentrations up to 100 μM. |
In vivo study | A 438079 (80 μmol/kg, i.v.) reduces noxious and innocuous evoked activity of different classes of spinal neurons in neuropathic rats. A 438079 (100 and 300 μmol/kg, i.p.) significantly raises withdrawal thresh-olds in both the SNL and CCI models. Intraperitoneal injection of A 438079 (5 and 15 mg/kg) 60 min after triggering seizures reduces seizure severity and neuronal death within the hippocampus. A 438079 has superior neuroprotective effects compared with an equally dose of phenobarbital (25 mg/kg).A 438079 partially but significantly prevents the 6-OHDA-induced depletion of striatal DA stores. Pretreatment with A 438079 reduces nociceptive behaviour scores in the HC model. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.919 ml | 14.594 ml | 29.188 ml |
5 mM | 0.584 ml | 2.919 ml | 5.838 ml |
10 mM | 0.292 ml | 1.459 ml | 2.919 ml |
5 mM | 0.058 ml | 0.292 ml | 0.584 ml |